Olympus announced an exclusive global distribution deal with MacroLux Medical Technology to distribute single-use urology ...

TAR-200 eliminated tumors in 82% of patients in a phase 2 trial for patients with high-risk non-muscle-invasive bladder ...

Traditional treatment for NMIBC includes transurethral resection of bladder tumor (TURBT), or standard resection (SR), allowing for the resection of all observable tumors without disruption to the ...

The U.S. Food and Drug Administration has approved Johnson & Johnson's drug delivery system for a type of bladder cancer, ...

There’s a new twist in the fight against bladder cancer — and it’s delivering game-changing results. In a recent clinical trial, a pretzel-shaped device that slowly releases chemotherapy drugs ...

US-based Virtuoso Surgical has completed the first-in-human bladder cancer removal cases using its surgical robotic system. The system features two robotically controlled, needle-sized manipulators ...

Urine for a breakthrough — in a true medical milestone, UCLA surgeons completed the world’s first in-human bladder transplant. Dr. Nima Nassiri, a urologic transplant surgeon and director of the UCLA ...

NASHVILLE--(BUSINESS WIRE)--Medical device company Virtuoso Surgical, Inc. has been awarded a $1.8 million Small Business Innovation Research (SBIR) NIH grant to be received over the next two years.

Olympus enters global distribution partnership with MacroLux Medical for single-use urology products: Westborough, Massachusetts Saturday, September 6, 2025, 15:00 Hrs [IST] Olymp ...